Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference
- 52
PR Newswire
BOULDER, Colo., Aug. 31, 2016
BOULDER, Colo., Aug. 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Wells Fargo Securities Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer |
|
Date: |
Wednesday, September 7, 2016 |
|
Time: |
9:50 a.m. Eastern Time |
|
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-wells-fargo-securities-healthcare-conference-300315055.html
SOURCE Array BioPharma Inc.
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
